XML 30 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Cumulative Common Distributions
Additional Paid in Capital
Cumulative Net Income
Cumulative Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018   164,441,709        
Beginning balance at Dec. 31, 2018 $ 2,597,431 $ 1,644 $ (5,181,323) $ 4,545,481 $ 3,231,895 $ (266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 259,750       259,750  
Amounts reclassified from cumulative other comprehensive income to net income 175         175
Equity in unrealized gains (losses) of investees 91         91
Common share grants (in shares)   155,100        
Common share grants $ 2,857 $ 2   2,855    
Common share repurchases (in shares) (31,225) (33,775)        
Common share repurchases $ (807)     (807)    
Distributions (353,619)   (353,619)      
Ending balance (in shares) at Dec. 31, 2019   164,563,034        
Ending balance at Dec. 31, 2019 2,505,878 $ 1,646 (5,534,942) 4,547,529 3,491,645 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (311,382)       (311,382)  
Amounts reclassified from cumulative other comprehensive income to net income 0          
Equity in unrealized gains (losses) of investees (760)         (760)
Common share grants (in shares)   305,400        
Common share grants $ 3,211 $ 2   3,209    
Common share repurchases (in shares) (43,751)          
Common share repurchases and forfeitures (in shares)   (44,601)        
Common share repurchases and forfeitures $ (353)     (353)    
Distributions (93,804)   (93,804)      
Ending balance (in shares) at Dec. 31, 2020   164,823,833        
Ending balance at Dec. 31, 2020 2,102,790 $ 1,648 (5,628,746) 4,550,385 3,180,263 (760)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (544,603)       (544,603)  
Amounts reclassified from cumulative other comprehensive income to net income 0          
Equity in unrealized gains (losses) of investees 1,539         1,539
Common share grants (in shares)   340,700        
Common share grants $ 2,967 $ 3   2,964    
Common share repurchases (in shares) (71,100)          
Common share repurchases and forfeitures (in shares)   (72,200)        
Common share repurchases and forfeitures $ (791)     (791)    
Distributions (6,596)   (6,596)      
Ending balance (in shares) at Dec. 31, 2021   165,092,333        
Ending balance at Dec. 31, 2021 $ 1,555,306 $ 1,651 $ (5,635,342) $ 4,552,558 $ 2,635,660 $ 779